BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16111664)

  • 21. Histopathologic alterations following local delivery of dexamethasone to inhibit restenosis in murine arteries.
    Pires NM; Schepers A; van der Hoeven BL; de Vries MR; Boesten LS; Jukema JW; Quax PH
    Cardiovasc Res; 2005 Dec; 68(3):415-24. PubMed ID: 16023630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model.
    Hou D; Narciso H; Kamdar K; Zhang P; Barclay B; March KL
    Cardiovasc Intervent Radiol; 2005; 28(1):60-5. PubMed ID: 15719180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rosuvastatin attenuates angiotensin II-induced neointimal formation after stent implantation in the rat.
    van der Harst P; Groenewegen HC; Roks AJ; Buikema H; Zijlstra F; van Gilst WH; de Smet BJ
    Coron Artery Dis; 2008 Feb; 19(1):47-53. PubMed ID: 18281816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of tacrolimus or sirolimus on proliferation of vascular smooth muscle and endothelial cells.
    Matter CM; Rozenberg I; Jaschko A; Greutert H; Kurz DJ; Wnendt S; Kuttler B; Joch H; Grünenfelder J; Zünd G; Tanner FC; Lüscher TF
    J Cardiovasc Pharmacol; 2006 Dec; 48(6):286-92. PubMed ID: 17204907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental efficacy of an everolimus eluting cobalt chromium stent.
    Carter AJ; Brodeur A; Collingwood R; Ross S; Gibson L; Wang CA; Haller S; Coleman L; Virmani R
    Catheter Cardiovasc Interv; 2006 Jul; 68(1):97-103. PubMed ID: 16755598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
    Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
    J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synergistic effects of a novel nanoporous stent coating and tacrolimus on intima proliferation in rabbits.
    Wieneke H; Dirsch O; Sawitowski T; Gu YL; Brauer H; Dahmen U; Fischer A; Wnendt S; Erbel R
    Catheter Cardiovasc Interv; 2003 Nov; 60(3):399-407. PubMed ID: 14571494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapamycin inhibits release of tumor necrosis factor-alpha from human vascular smooth muscle cells.
    Adkins JR; Castresana MR; Wang Z; Newman WH
    Am Surg; 2004 May; 70(5):384-7; discussion 387-8. PubMed ID: 15156944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stent-based delivery of tissue inhibitor of metalloproteinase-3 adenovirus inhibits neointimal formation in porcine coronary arteries.
    Johnson TW; Wu YX; Herdeg C; Baumbach A; Newby AC; Karsch KR; Oberhoff M
    Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):754-9. PubMed ID: 15681295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-eluting stents.
    García-García HM; Vaina S; Tsuchida K; Serruys PW
    Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Local delivery of imatinib mesylate (STI571)-incorporated nanoparticle ex vivo suppresses vein graft neointima formation.
    Kimura S; Egashira K; Nakano K; Iwata E; Miyagawa M; Tsujimoto H; Hara K; Kawashima Y; Tominaga R; Sunagawa K
    Circulation; 2008 Sep; 118(14 Suppl):S65-70. PubMed ID: 18824771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of ribonucleotide reductase reduces neointimal formation following balloon injury.
    Henry JC; Bonar MM; Kearns PN; Cui H; Mutchler MM; Martin MV; Orsini AR; Elford HL; Bush CA; Zweier JL; Cardounel AJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):70-6. PubMed ID: 15814568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries.
    Ialenti A; Grassia G; Gordon P; Maddaluno M; Di Lauro MV; Baker AH; Guglielmotti A; Colombo A; Biondi G; Kennedy S; Maffia P
    Arterioscler Thromb Vasc Biol; 2011 Nov; 31(11):2448-54. PubMed ID: 21852559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally administered rapamycin does not modify rat aortic vascular tone.
    Neto Mde M; Di Marco GS; Casarini DE; Lima VC; Campos AH
    J Cardiovasc Pharmacol; 2007 Feb; 49(2):96-9. PubMed ID: 17312450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 3-Deazaadenosine prevents smooth muscle cell proliferation and neointima formation by interfering with Ras signaling.
    Sedding DG; Tröbs M; Reich F; Walker G; Fink L; Haberbosch W; Rau W; Tillmanns H; Preissner KT; Bohle RM; Langheinrich AC
    Circ Res; 2009 May; 104(10):1192-200. PubMed ID: 19372464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective role of clusterin/apolipoprotein J against neointimal hyperplasia via antiproliferative effect on vascular smooth muscle cells and cytoprotective effect on endothelial cells.
    Kim HJ; Yoo EK; Kim JY; Choi YK; Lee HJ; Kim JK; Jeoung NH; Lee KU; Park IS; Min BH; Park KG; Lee CH; Aronow BJ; Sata M; Lee IK
    Arterioscler Thromb Vasc Biol; 2009 Oct; 29(10):1558-64. PubMed ID: 19696405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukotriene receptor antagonism and the prevention of extracellular matrix degradation during atherosclerosis and in-stent stenosis.
    Hlawaty H; Jacob MP; Louedec L; Letourneur D; Brink C; Michel JB; Feldman L; Bäck M
    Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):518-24. PubMed ID: 19164806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time dependent vascular and myocardial responses of a second generation, small vessel, paclitaxel-eluting stent platform.
    Thompson CA; Huibregtse B; Poff B; Wilson GJ
    Catheter Cardiovasc Interv; 2009 Apr; 73(5):597-604. PubMed ID: 19180652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Late outgrowth endothelial cells derived from Wharton jelly in human umbilical cord reduce neointimal formation after vascular injury: involvement of pigment epithelium-derived factor.
    Wang SH; Lin SJ; Chen YH; Lin FY; Shih JC; Wu CC; Wu HL; Chen YL
    Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):816-22. PubMed ID: 19342598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.